Matches in SemOpenAlex for { <https://semopenalex.org/work/W4211029239> ?p ?o ?g. }
- W4211029239 endingPage "355" @default.
- W4211029239 startingPage "355" @default.
- W4211029239 abstract "Patients with chronic kidney disease (CKD), especially those who are hemodialyzed (HD), are at significantly high risk of contracting cardiovascular disease and having increased mortality. This study aimed to find potential death predictors, the measurement of which may reflect increased mortality in HD patients, and then combine the most promising ones in frames of a simple death risk assessment model. For this purpose, HD patients (n=71) with acute myocardial infarction in the last year (HD group) and healthy people (control group) as a comparative group (n=32) were included in the study. Various laboratory determinations and non-invasive cardiovascular tests were performed. Next, patients were followed for two years, and data on cardiovascular (CV) deaths were collected. On this basis, two HD groups were formed: patients who survived (HD-A, n=51) and patients who died (HD-D, n=20). To model HD mortality, 21 out of 90 potential variables collected or calculated from the raw data were selected. The best explanatory power (95.5%) was reached by a general linear model with four variables: interleukin 18, 3-nitrotyrosine, albumin, and phosphate. The interplay between immuno-inflammatory processes, nitrosative and oxidative stress, malnutrition, and calcium-phosphate disorders has been indicated to be essential in predicting CV-related mortality in studied HD patients. ClinicalTrials.gov Identifier: NCT05214872." @default.
- W4211029239 created "2022-02-13" @default.
- W4211029239 creator A5002189961 @default.
- W4211029239 creator A5004565826 @default.
- W4211029239 creator A5045236904 @default.
- W4211029239 creator A5054092040 @default.
- W4211029239 date "2022-02-11" @default.
- W4211029239 modified "2023-09-26" @default.
- W4211029239 title "The Mutual Contribution of 3-NT, IL-18, Albumin, and Phosphate Foreshadows Death of Hemodialyzed Patients in a 2-Year Follow-Up" @default.
- W4211029239 cites W1262221680 @default.
- W4211029239 cites W1485382152 @default.
- W4211029239 cites W1516311606 @default.
- W4211029239 cites W1526950608 @default.
- W4211029239 cites W1577016644 @default.
- W4211029239 cites W1965899716 @default.
- W4211029239 cites W1967167614 @default.
- W4211029239 cites W1968145446 @default.
- W4211029239 cites W1972745246 @default.
- W4211029239 cites W1992205536 @default.
- W4211029239 cites W1998627678 @default.
- W4211029239 cites W2004453509 @default.
- W4211029239 cites W2024362563 @default.
- W4211029239 cites W2055573732 @default.
- W4211029239 cites W2069299951 @default.
- W4211029239 cites W2073789348 @default.
- W4211029239 cites W2081385953 @default.
- W4211029239 cites W2081417501 @default.
- W4211029239 cites W2086615343 @default.
- W4211029239 cites W2097502821 @default.
- W4211029239 cites W2098065069 @default.
- W4211029239 cites W2109576876 @default.
- W4211029239 cites W2113079363 @default.
- W4211029239 cites W2124401980 @default.
- W4211029239 cites W2135899868 @default.
- W4211029239 cites W2137117155 @default.
- W4211029239 cites W2138382873 @default.
- W4211029239 cites W2138676060 @default.
- W4211029239 cites W2150551517 @default.
- W4211029239 cites W2155270563 @default.
- W4211029239 cites W2158940116 @default.
- W4211029239 cites W2159809881 @default.
- W4211029239 cites W2219033632 @default.
- W4211029239 cites W2309368936 @default.
- W4211029239 cites W2320305253 @default.
- W4211029239 cites W2333333141 @default.
- W4211029239 cites W2439161892 @default.
- W4211029239 cites W2507623544 @default.
- W4211029239 cites W2550997335 @default.
- W4211029239 cites W2589588206 @default.
- W4211029239 cites W2591537657 @default.
- W4211029239 cites W2617615685 @default.
- W4211029239 cites W2742219191 @default.
- W4211029239 cites W2756324351 @default.
- W4211029239 cites W2765137883 @default.
- W4211029239 cites W2789391161 @default.
- W4211029239 cites W2792102197 @default.
- W4211029239 cites W2809682856 @default.
- W4211029239 cites W2896259415 @default.
- W4211029239 cites W2899661122 @default.
- W4211029239 cites W2904356389 @default.
- W4211029239 cites W2911258948 @default.
- W4211029239 cites W2923787619 @default.
- W4211029239 cites W2969064380 @default.
- W4211029239 cites W2974932310 @default.
- W4211029239 cites W3005090205 @default.
- W4211029239 cites W3005957464 @default.
- W4211029239 cites W3014472248 @default.
- W4211029239 cites W3029577837 @default.
- W4211029239 cites W3032380923 @default.
- W4211029239 cites W3049004220 @default.
- W4211029239 cites W3092480936 @default.
- W4211029239 cites W3093411401 @default.
- W4211029239 cites W3101145531 @default.
- W4211029239 cites W3123087664 @default.
- W4211029239 cites W3135454698 @default.
- W4211029239 cites W3135905702 @default.
- W4211029239 cites W3156468205 @default.
- W4211029239 cites W3157719789 @default.
- W4211029239 cites W3158582290 @default.
- W4211029239 cites W3165218810 @default.
- W4211029239 cites W3176491769 @default.
- W4211029239 cites W3191110339 @default.
- W4211029239 cites W4313331914 @default.
- W4211029239 doi "https://doi.org/10.3390/antiox11020355" @default.
- W4211029239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35204237" @default.
- W4211029239 hasPublicationYear "2022" @default.
- W4211029239 type Work @default.
- W4211029239 citedByCount "1" @default.
- W4211029239 countsByYear W42110292392022 @default.
- W4211029239 crossrefType "journal-article" @default.
- W4211029239 hasAuthorship W4211029239A5002189961 @default.
- W4211029239 hasAuthorship W4211029239A5004565826 @default.
- W4211029239 hasAuthorship W4211029239A5045236904 @default.
- W4211029239 hasAuthorship W4211029239A5054092040 @default.
- W4211029239 hasBestOaLocation W42110292391 @default.
- W4211029239 hasConcept C126322002 @default.
- W4211029239 hasConcept C141071460 @default.
- W4211029239 hasConcept C2776125364 @default.